Mark E. Dmytruk - Chief Financial Officer at Ginkgo Bioworks Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
DNA, DNA-WT on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Mark E. Dmytruk - trading volume in the past year for Ginkgo Bioworks Holdings, Inc.

Holdings reported by Mark E. Dmytruk for Ginkgo Bioworks Holdings, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 1,008,334 $554 K $0.55 Jul 1, 2024 Direct Class A Common Stock
Class B Common Stock 623,777 $342 K $0.55 Jul 1, 2024 Direct Class A Common Stock
Class A Common Stock 1,043,626 $340 K $0.33 Jul 2, 2024 Direct

Transactions reported by Mark E. Dmytruk for Ginkgo Bioworks Holdings, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership